As of close of business last night, Spyre Therapeutics Inc.’s stock clocked out at $40.26, up 6.93% from its previous closing price of $37.65. In other words, the price has increased by $+2.61 from its previous closing price. On the day, 869527 shares were traded. SYRE stock price reached its highest trading level at $40.81 during the session, while it also had its lowest trading level at $36.15.
Ratios:
To gain a deeper understanding of SYRE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.68 and its Current Ratio is at 10.68. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.46.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on March 01, 2024, Upgraded its rating to Overweight and sets its target price to $35 from $12 previously.
On December 20, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $32.
On December 11, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $31.Jefferies initiated its Buy rating on December 11, 2023, with a $31 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SYRE now has a Market Capitalization of 1.36B and an Enterprise Value of 1.21B. For the stock, the TTM Price-to-Sale (P/S) ratio is 1635.28. Its current Enterprise Value per Revenue stands at 1.36k whereas that against EBITDA is -9.44.
Stock Price History:
Over the past 52 weeks, SYRE has reached a high of $39.77, while it has fallen to a 52-week low of $2.66. The 50-Day Moving Average of the stock is 24.04, while the 200-Day Moving Average is calculated to be 14.68.
Shares Statistics:
It appears that SYRE traded 375.99K shares on average per day over the past three months and 855.87k shares per day over the past ten days. A total of 36.06M shares are outstanding, with a floating share count of 32.15M. Insiders hold about 11.05% of the company’s shares, while institutions hold 70.28% stake in the company. Shares short for SYRE as of Feb 15, 2024 were 1.59M with a Short Ratio of 4.23, compared to 527.39k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.41% and a Short% of Float of 4.41%.
Earnings Estimates
As of right now, 6 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$1.03 for the current quarter, with a high estimate of -$0.34 and a low estimate of -$1.78, while EPS last year was -$5. The consensus estimate for the next quarter is -$0.85, with high estimates of -$0.34 and low estimates of -$1.81.
Analysts are recommending an EPS of between -$1.37 and -$7.28 for the fiscal current year, implying an average EPS of -$3.44. EPS for the following year is -$3.05, with 7 analysts recommending between -$1.4 and -$4.67.
